EVERLASTING FOUNDATION Broad Spectrum SPF15 sienna 118

Manufacturer: Laboratoires Clarins S.A.
Effective date: 2019-12-19
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-01 23:49:48

Label at a glance#

ProductEVERLASTING FOUNDATION Broad Spectrum SPF15 sienna 118

Active ingredientTITANIUM DIOXIDE

Label structure9 sections

Indications and uses

helps prevent sunburn if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage and administration

• apply liberally 15 minutes before sun exposure • apply to all skin exposed to the sun • children under 6 months: Ask a doctor • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 ...

Contacts and useful links#

PhoneLabel contact1-866-252-7467

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

TITANIUM DIOXIDE 1.9%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses:

INDICATIONS & USAGE SECTION

helps prevent sunburn
if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings:

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

on damaged or broken skin

When using this product

OTC - WHEN USING SECTION

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

OTC - STOP USE SECTION

rash occurs.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions:

DOSAGE & ADMINISTRATION SECTION

• apply liberally 15 minutes before sun exposure
• apply to all skin exposed to the sun
• children under 6 months: Ask a doctor
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly
use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
• limit time in the sun, especially from 10 a.m. – 2 p.m.
• wear long-sleeved shirts, pants, hats and sunglasses.
• reapply at least every 2 hours
• use a water resistant sunscreen if swimming or sweating.

Inactive ingredients

INACTIVE INGREDIENT SECTION

AQUA/WATER/EAU . DICAPRYLYL CARBONATE . C10-13 ALKANE . METHYL METHACRYLATE CROSSPOLYMER . ALCOHOL . BUTYLENE GLYCOL . C12-15 ALKYL BENZOATE . CETYL PEG/PPG-10/1 DIMETHICONE . DIMETHICONE . SODIUM CHLORIDE . COCO-CAPRYLATE/CAPRATE . METHYL TRIMETHICONE . SILICA . POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE . ALUMINUM HYDROXIDE . ACRYLATES/DIMETHICONE COPOLYMER . BAMBUSA ARUNDINACEA STEM EXTRACT . PARFUM/ FRAGRANCE . STEARALKONIUM HECTORITE . STEARIC ACID . SYNTHETIC FLUORPHLOGOPITE . ETHYLHEXYLGLYCERIN . TOCOPHERYL ACETATE . PROPYLENE CARBONATE . DISODIUM EDTA . HYDROXYETHYL UREA . SODIUM LAUROYL GLUTAMATE . CHENOPODIUM QUINOA SEED EXTRACT . LYSINE . MAGNESIUM CHLORIDE . CAMELLIA SINENSIS LEAF EXTRACT . PHENOXYETHANOL. LAPSANA COMMUNIS FLOWER/LEAF/STEM EXTRACT . ALGIN . ACACIA SENEGAL GUM . SODIUM BENZOATE.
± / MAY CONTAIN/PEUT CONTENIR : CI 77891/TITANIUM DIOXIDE . CI 77491/CI 77492/CI 77499/IRON OXIDES. [M2720A

Other information:

SPL UNCLASSIFIED SECTION

• protect this product from excessive heat and direct sun.

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-866-252-7467 (In the US) Monday-Friday, 8 a.m. to 5 p.m.

Everlasting Foundation +,

SPL UNCLASSIFIED SECTION

18 hours* of long-lasting coverage and comfort.
Complexion perfection* without compromising comfort.
• A flawless, even complexion. Dark spots, redness and imperfections are concealed.
• A perfect complexion from morning to night, no touch-ups needed.
• A formula enriched with organic quinoa extract for supple, comfortable skin. Matte finish. Full coverage. All skin types.
Dermatologist tested. No-transfer formula**. Non-comedogenic. Oil-free. Clarins exclusive anti-pollution protection. *Satisfaction test - 60 women. **Instrumental test - 19 women.

CLARINS 92200 Neuilly-sur-Seine 95300 Pontoise - France Made in France

Product Labels

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

OuterBox118Shade118BottleLabelNoticeLabel

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	2
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	2
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	2
ALUMINUM HYDROXIDE	INACTIVE INGREDIENT	5QB0T2IUN0	2
BAMBUSA ARUNDINACEA STEM	INACTIVE INGREDIENT	NRA4497HC5	2
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	2
C12-15 ALKYL BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	2
CHENOPODIUM QUINOA SEED	INACTIVE INGREDIENT	OO4K72NZ2X	2
COCO-CAPRYLATE/CAPRATE	INACTIVE INGREDIENT	8D9H4QU99H	2
DICAPRYLYL CARBONATE	INACTIVE INGREDIENT	609A3V1SUA	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	2
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	2
GREEN TEA LEAF	INACTIVE INGREDIENT	W2ZU1RY8B0	2
HYDROXYETHYL UREA	INACTIVE INGREDIENT	MBQ7DDQ7AR	2
LAPSANA COMMUNIS FLOWERING TOP	INACTIVE INGREDIENT	T9B77O7PZA	2
LYSINE	INACTIVE INGREDIENT	K3Z4F929H6	2
MAGNESIUM CHLORIDE	INACTIVE INGREDIENT	02F3473H9O	2
METHYL TRIMETHICONE	INACTIVE INGREDIENT	S73ZQI0GXM	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	2
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	2
SODIUM ALGINATE	INACTIVE INGREDIENT	C269C4G2ZQ	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	2
SODIUM LAUROYL GLUTAMATE	INACTIVE INGREDIENT	NCX1UU2D33	2
STEARALKONIUM HECTORITE	INACTIVE INGREDIENT	OLX698AH5P	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 29 matching rows.

EVERLASTING FOUNDATION Broad Spectrum SPF15 sienna 118
TITANIUM DIOXIDE
WATER
DICAPRYLYL CARBONATE
ALCOHOL
BUTYLENE GLYCOL
ALKYL (C12-15) BENZOATE
DIMETHICONE
SODIUM CHLORIDE
COCO-CAPRYLATE/CAPRATE
METHYL TRIMETHICONE
SILICON DIOXIDE
ALUMINUM HYDROXIDE
BAMBUSA ARUNDINACEA STEM
STEARALKONIUM HECTORITE
STEARIC ACID
ETHYLHEXYLGLYCERIN
.ALPHA.-TOCOPHEROL ACETATE
PROPYLENE CARBONATE
EDETATE DISODIUM
HYDROXYETHYL UREA
SODIUM LAUROYL GLUTAMATE
CHENOPODIUM QUINOA SEED
LYSINE
MAGNESIUM CHLORIDE
GREEN TEA LEAF
PHENOXYETHANOL
LAPSANA COMMUNIS FLOWERING TOP
SODIUM ALGINATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
58668-7250	58668-7250-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
DICAPRYLYL CARBONATE	609A3V1SUA	IACT
ALCOHOL	3K9958V90M	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
ALKYL (C12-15) BENZOATE	A9EJ3J61HQ	IACT
DIMETHICONE	92RU3N3Y1O	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
COCO-CAPRYLATE/CAPRATE	8D9H4QU99H	IACT
METHYL TRIMETHICONE	S73ZQI0GXM	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
ALUMINUM HYDROXIDE	5QB0T2IUN0	IACT
BAMBUSA ARUNDINACEA STEM	NRA4497HC5	IACT
STEARALKONIUM HECTORITE	OLX698AH5P	IACT
STEARIC ACID	4ELV7Z65AP	IACT
ETHYLHEXYLGLYCERIN	147D247K3P	IACT
.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	IACT
PROPYLENE CARBONATE	8D08K3S51E	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
HYDROXYETHYL UREA	MBQ7DDQ7AR	IACT
SODIUM LAUROYL GLUTAMATE	NCX1UU2D33	IACT
CHENOPODIUM QUINOA SEED	OO4K72NZ2X	IACT
LYSINE	K3Z4F929H6	IACT
MAGNESIUM CHLORIDE	02F3473H9O	IACT
GREEN TEA LEAF	W2ZU1RY8B0	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
LAPSANA COMMUNIS FLOWERING TOP	T9B77O7PZA	IACT
SODIUM ALGINATE	C269C4G2ZQ	IACT
TITANIUM DIOXIDE	15FIX9V2JP	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 380 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION, EMULSION / INTRAVENOUS		59 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	TABLET / ORAL	0.5 mg		Exact identifier — unii candidate 3 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / PERINEURAL		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	AEROSOL, SPRAY / TOPICAL		561 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	DROPS / AURICULAR (OTIC)	0.05 %w/w		Exact identifier — unii candidate 77 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET, CHEWABLE / ORAL		180 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION, SOLUTION / INTRAVENOUS		6405 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
COCO-CAPRYLATE/CAPRATE	COCOYL CAPRYLOCAPRATE	8D9H4QU99H	GEL / TOPICAL	2.5 %w/w		Exact identifier — unii candidate
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / AURICULAR (OTIC)	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / ORAL		432 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	TABLET, EXTENDED RELEASE / ORAL		627 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	CONCENTRATE / BUCCAL	679 mg/1ml		Exact identifier — unii candidate 59 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION / DENTAL	12.8 %w/w		Exact identifier — unii candidate 59 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED / ORAL		166 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / TOPICAL		210 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	CAPSULE / ORAL		882 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / INTRA-ARTERIAL		278 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL	1.35 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	TABLET / ORAL		480 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION / TOPICAL		2445 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / EPIDURAL	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, EMULSION / INTRAVENOUS	0.62 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	LIQUID / INTRAVENOUS	0.03 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	TABLET, ORALLY DISINTEGRATING / ORAL		3 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SUSPENSION / ORAL		30 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	CREAM / VAGINAL		1088 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INFILTRATION		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / SUBCUTANEOUS	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
LYSINE	LYSINE	K3Z4F929H6	INJECTION / INTRAMUSCULAR	NA		Exact identifier — unii candidate 3 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	CAPSULE / ORAL	2 mg		Exact identifier — unii candidate 3 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	LIQUID / NASAL	2 mg/1ml		Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	DROPS / NASAL	0.1 mg/1ml		Exact identifier — unii candidate 77 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	IMPLANT / SUBCUTANEOUS	1.04 mg		Exact identifier — unii candidate 26 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		360 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	OINTMENT / TOPICAL		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / INTRAVENOUS	0.05 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
ALUMINUM HYDROXIDE	ALUMINUM HYDROXIDE	5QB0T2IUN0	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 4 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	POWDER, FOR SUSPENSION / ORAL	1203 mg/5ml		Exact identifier — unii candidate 26 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SPRAY / TOPICAL		3633 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL	226 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	SOLUTION / OPHTHALMIC	0.01 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET / BUCCAL	6 mg		Exact identifier — unii candidate 26 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / AURICULAR (OTIC)		18 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRASYNOVIAL	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / NASAL	100 mg/100ml		Exact identifier — unii candidate 77 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	AEROSOL, FOAM / VAGINAL	4 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	ELIXIR / ORAL	1.3 mg/5ml		Exact identifier — unii candidate 77 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TRANSDERMAL	8.12 mg		Exact identifier — unii candidate 2 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / OPHTHALMIC		10 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE / ORAL		254 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / AURICULAR (OTIC)	0.1 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / NASAL		20 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	DROPS / OPHTHALMIC	0.08 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LIQUID / INTRAMUSCULAR		17 mg	Exact identifier — unii candidate 134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
d07d103d-420a-5307-e053-2995a90a14f5			ea8abeab-b467-4ed3-9727-45f2f632843a	2021-11-10	Warnings	Exact identifier spl set id: ea8abeab-b467-4ed3-9727-45f2f632843a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.